Modelling to infer the role of animals in gambiense human African trypanosomiasis transmission and elimination in the DRC.


Journal

PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488

Informations de publication

Date de publication:
07 2022
Historique:
received: 23 12 2021
accepted: 22 06 2022
revised: 21 07 2022
pubmed: 12 7 2022
medline: 26 7 2022
entrez: 11 7 2022
Statut: epublish

Résumé

Gambiense human African trypanosomiasis (gHAT) has been targeted for elimination of transmission (EoT) to humans by 2030. Whilst this ambitious goal is rapidly approaching, there remain fundamental questions about the presence of non-human animal transmission cycles and their potential role in slowing progress towards, or even preventing, EoT. In this study we focus on the country with the most gHAT disease burden, the Democratic Republic of Congo (DRC), and use mathematical modelling to assess whether animals may contribute to transmission in specific regions, and if so, how their presence could impact the likelihood and timing of EoT. By fitting two model variants-one with, and one without animal transmission-to the human case data from 2000-2016 we estimate model parameters for 158 endemic health zones of the DRC. We evaluate the statistical support for each model variant in each health zone and infer the contribution of animals to overall transmission and how this could impact predicted time to EoT. We conclude that there are 24/158 health zones where there is substantial to decisive statistical support for some animal transmission. However-even in these regions-we estimate that animals would be extremely unlikely to maintain transmission on their own. Animal transmission could hamper progress towards EoT in some settings, with projections under continuing interventions indicating that the number of health zones expected to achieve EoT by 2030 reduces from 68/158 to 61/158 if animal transmission is included in the model. With supplementary vector control (at a modest 60% tsetse reduction) added to medical screening and treatment interventions, the predicted number of health zones meeting the goal increases to 147/158 for the model including animal transmission. This is due to the impact of vector reduction on transmission to and from all hosts.

Identifiants

pubmed: 35816487
doi: 10.1371/journal.pntd.0010599
pii: PNTD-D-21-01789
pmc: PMC9302778
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0010599

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

PLoS Negl Trop Dis. 2020 Oct 16;14(10):e0008270
pubmed: 33064783
PLoS Comput Biol. 2021 Sep 13;17(9):e1009367
pubmed: 34516544
PLoS Biol. 2019 Jan 11;17(1):e3000105
pubmed: 30633739
Trends Parasitol. 2018 Mar;34(3):197-207
pubmed: 29396200
PLoS Negl Trop Dis. 2017 Jul 27;11(7):e0005792
pubmed: 28750007
PLoS Negl Trop Dis. 2020 Apr 9;14(4):e0008033
pubmed: 32271755
J Infect Dis. 2020 Jun 11;221(Suppl 5):S539-S545
pubmed: 31876949
Parasit Vectors. 2015 Oct 22;8:532
pubmed: 26490248
Parasite. 2020;27:63
pubmed: 33206595
PLoS Negl Trop Dis. 2018 Dec 6;12(12):e0006890
pubmed: 30521525
Clin Infect Dis. 2021 Jun 14;72(Suppl 3):S146-S151
pubmed: 33905480
PLoS Negl Trop Dis. 2017 Apr 20;11(4):e0005495
pubmed: 28426663
Parasit Vectors. 2015 Oct 22;8:550
pubmed: 26490037
PLoS Negl Trop Dis. 2015 Aug 12;9(8):e0003727
pubmed: 26267667
Trans R Soc Trop Med Hyg. 2021 Mar 6;115(3):245-252
pubmed: 33611586
Int J Health Geogr. 2010 Nov 01;9:57
pubmed: 21040555
J R Soc Interface. 2020 Dec;17(173):20200540
pubmed: 33292098
Emerg Infect Dis. 2002 Dec;8(12):1468-73
pubmed: 12498665
World Health Organ Tech Rep Ser. 2013;(984):1-237
pubmed: 24552089
Trends Parasitol. 2004 Aug;20(8):347-51
pubmed: 15246314
Trans R Soc Trop Med Hyg. 1947 Jul;40(6):728-61
pubmed: 20262300
PLoS Comput Biol. 2015 Oct 01;11(10):e1004514
pubmed: 26426854
PLoS Negl Trop Dis. 2015 Aug 12;9(8):e0003822
pubmed: 26267814
Nat Commun. 2022 Mar 18;13(1):1448
pubmed: 35304479
PLoS Comput Biol. 2021 Jan 29;17(1):e1008532
pubmed: 33513134
Epidemics. 2017 Mar;18:101-112
pubmed: 28279451
Clin Epidemiol. 2014 Aug 06;6:257-75
pubmed: 25125985
Infect Dis Poverty. 2022 Jan 24;11(1):11
pubmed: 35074016
Elife. 2016 Sep 22;5:
pubmed: 27653219
PLoS Negl Trop Dis. 2012 Jan;6(1):e1467
pubmed: 22272367
PLoS Comput Biol. 2013;9(1):e1002855
pubmed: 23341760
Trop Med Infect Dis. 2020 Oct 13;5(4):
pubmed: 33066254
PLoS Negl Trop Dis. 2020 May 21;14(5):e0008261
pubmed: 32437391
PLoS Negl Trop Dis. 2020 Jan 21;14(1):e0007976
pubmed: 31961872

Auteurs

Ronald E Crump (RE)

Zeeman Institute for Systems Biology and Infectious Disease Epidemiology Research, The University of Warwick, Coventry, United Kingdom.
Mathematics Institute, The University of Warwick, Coventry, United Kingdom.

Ching-I Huang (CI)

Zeeman Institute for Systems Biology and Infectious Disease Epidemiology Research, The University of Warwick, Coventry, United Kingdom.
Mathematics Institute, The University of Warwick, Coventry, United Kingdom.

Simon E F Spencer (SEF)

Zeeman Institute for Systems Biology and Infectious Disease Epidemiology Research, The University of Warwick, Coventry, United Kingdom.
The Department of Statistics, The University of Warwick, Coventry, United Kingdom.

Paul E Brown (PE)

Zeeman Institute for Systems Biology and Infectious Disease Epidemiology Research, The University of Warwick, Coventry, United Kingdom.
Mathematics Institute, The University of Warwick, Coventry, United Kingdom.

Chansy Shampa (C)

Programme National de Lutte contre la Trypanosomiase Humaine Africaine (PNLTHA), Kinshasa, Democratic Republic of the Congo.

Erick Mwamba Miaka (E)

Programme National de Lutte contre la Trypanosomiase Humaine Africaine (PNLTHA), Kinshasa, Democratic Republic of the Congo.

Kat S Rock (KS)

Zeeman Institute for Systems Biology and Infectious Disease Epidemiology Research, The University of Warwick, Coventry, United Kingdom.
Mathematics Institute, The University of Warwick, Coventry, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH